Health in the 2030 Agenda for Sustainable Development: from framework to action, transforming challenges into...

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.

Here, we present a protocol for active site validation of metal-organic framework catalysts by comparing stoichiometric and catalytic carbonyl-ene reactions to find out whether a reaction takes place on the inner or outer surface of metal-organic...

A basic protocol for fabricating high-transconductance Melanin/PEDOT:PSS organic electrochemical transistors (OECTs) using spray coating is described. The method allows precise control over film deposition, thickness, and morphology, providing reproducible devices for sustainable and scalable bioelectronic...

Synthesis, activation, and characterization of intentionally designed metal-organic framework materials is challenging, especially when building blocks are incompatible or unwanted polymorphs are thermodynamically favored over desired forms. We describe how applications of solvent-assisted linker exchange, powder X-ray diffraction in capillaries and activation via supercritical CO2 drying, can address some of these...

Opportunity cost refers to the value of the next best alternative that must be forgone when making a decision. It represents the potential benefits or opportunities sacrificed when choosing one option over another. Understanding opportunity cost is essential in decision-making as it helps individuals, businesses, and societies assess the true cost of their choices.
In life, every decision involves trade-offs, where opting for one alternative means giving up another. For example, pursuing higher...

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...